Does SULFASALAZINE Cause Basal cell carcinoma? 598 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 598 reports of Basal cell carcinoma have been filed in association with SULFASALAZINE (Azulfidine EN-tabs). This represents 1.5% of all adverse event reports for SULFASALAZINE.
598
Reports of Basal cell carcinoma with SULFASALAZINE
1.5%
of all SULFASALAZINE reports
0
Deaths
546
Hospitalizations
How Dangerous Is Basal cell carcinoma From SULFASALAZINE?
Of the 598 reports, 546 (91.3%) required hospitalization, and 20 (3.3%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SULFASALAZINE. However, 598 reports have been filed with the FAERS database.
What Other Side Effects Does SULFASALAZINE Cause?
Drug ineffective (22,365)
Rheumatoid arthritis (15,136)
Drug intolerance (11,530)
Pain (11,309)
Fatigue (9,684)
Joint swelling (9,673)
Rash (8,739)
Contraindicated product administered (8,698)
Arthralgia (8,527)
Abdominal discomfort (8,404)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which SULFASALAZINE Alternatives Have Lower Basal cell carcinoma Risk?
SULFASALAZINE vs SULFATHIAZOLE
SULFASALAZINE vs SULFISOMIDINE
SULFASALAZINE vs SULFUR
SULFASALAZINE vs SULFUR HEXAFLUORIDE
SULFASALAZINE vs SULINDAC